Role of inflammatory cytokines in depression: Focus on interleukin-1β (Review)
- Authors:
- Rai Khalid Farooq
- Kashif Asghar
- Shahzina Kanwal
- Ali Zulqernain
-
Affiliations: Department of Physiology, Army Medical College, National University of Medical Sciences, Rawalpindi, Punjab 46000, Pakistan, Department of Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Punjab 54000, Pakistan, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510000, P.R. China, Department of Psychiatry and Behavioral Sciences, Sargodha Medical College, University of Sargodha, Sargodha, Punjab 40100, Pakistan - Published online on: November 10, 2016 https://doi.org/10.3892/br.2016.807
- Pages: 15-20
This article is mentioned in:
Abstract
|
Mathers CD and Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3:e4422006. View Article : Google Scholar : PubMed/NCBI | |
|
Seligman ME and Csikszentmihalyi M: Positive psychology: an introduction. Springer. Netherlands, Dordrecht: 279–298. 2014. | |
|
Murphy DL, Cohen RM, Siever LJ, Roy B, Karoum F, Wyatt RJ, Garrick NA and Linnoila M: Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects. Mod Probl Pharmacopsychiatry. 19:287–303. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Ader R and Cohen N: High time for psychoimmunology. Nature. 315:103–104. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Maes M: Evidence for an immune response in major depression: A review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 19:11–38. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Maes M, Berk M, Goehler L, Song C, Anderson G, Gałecki P and Leonard B: Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 10:662012. View Article : Google Scholar : PubMed/NCBI | |
|
Skaper SD, Facci L and Giusti P: Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. CNS Neurol Disord Drug Targets. 13:1654–1666. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Maes M, Van de Vyvere J, Vandoolaeghe E, Bril T, Demedts P, Wauters A and Neels H: Alterations in iron metabolism and the erythron in major depression: Further evidence for a chronic inflammatory process. J Affect Disord. 40:23–33. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Smith RS: The macrophage theory of depression. Med Hypotheses. 35:298–306. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Patel A: Review: The role of inflammation in depression. Psychiatr Danub. 25:(Suppl 2). S216–S223. 2013.PubMed/NCBI | |
|
Dantzer R: Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 29:247–264. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hart BL: Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 12:123–137. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Kent S, Bluthe RM, Dantzer R, Hardwick AJ, Kelley KW, Rothwell NJ and Vannice JL: Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci USA. 89:9117–9120. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Raison CL, Capuron L and Miller AH: Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 27:24–31. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Irwin M: Immune correlates of depression. Adv Exp Med Biol. 461:1–24. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Cruess DG, Douglas SD, Petitto JM, Have TT, Gettes D, Dubé B, Cary M and Evans DL: Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am J Psychiatry. 162:2125–2130. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Evans DL, Ten Have TR, Douglas SD, Gettes DR, Morrison M, Chiappini MS, Brinker-Spence P, Job C, Mercer DE, Wang YL, et al: Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 159:1752–1759. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Pike JL and Irwin MR: Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder. Brain Behav Immun. 20:169–174. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Papanicolaou DA, Wilder RL, Manolagas SC and Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 128:127–137. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Ho RC and Mak A: Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression. J Affect Disord. 139:230–239. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Brebner K, Hayley S, Zacharko R, Merali Z and Anisman H: Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α: Central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology. 22:566–580. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Yudkin JS, Kumari M, Humphries SE and Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis. 148:209–214. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Carvalho LA, Urbanova L, Hamer M, Hackett RA, Lazzarino AI and Steptoe A: Blunted glucocorticoid and mineralocorticoid sensitivity to stress in people with diabetes. Psychoneuroendocrinology. 51:209–218. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
McInnis CM, Thoma MV, Gianferante D, Hanlin L, Chen X, Breines JG, Hong S and Rohleder N: Measures of adiposity predict interleukin-6 responses to repeated psychosocial stress. Brain Behav Immun. 42:33–40. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ershler WB and Keller ET: Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 51:245–270. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Windham BG, Simpson BN, Lirette S, Bridges J, Bielak L, Peyser PA, Kullo I, Turner S, Griswold ME and Mosley TH: Associations between inflammation and cognitive function in African Americans and European Americans. J Am Geriatr Soc. 62:2303–2310. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Huber SA, Sakkinen P, Conze D, Hardin N and Tracy R: Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 19:2364–2367. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang T, Chen Y, Liu H, Zhou Z, Zhai Y and Yang J: Chronic unpredictable stress accelerates atherosclerosis through promoting inflammation in apolipoprotein E knockout mice. Thromb Res. 126:386–392. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Song C, Dinan T and Leonard BE: Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord. 30:283–288. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Yudkin JS, Yajnik CS, Mohamed-Ali V and Bulmer K: High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease. Diabetes Care. 22:363–364. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Baker DG, Ekhator NN, Kasckow JW, Hill KK, Zoumakis E, Dashevsky BA, Chrousos GP and Geracioti TD Jr: Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation. 9:209–217. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR and Maier SF: Exposure to acute stress induces brain interleukin-1β protein in the rat. J Neurosci. 18:2239–2246. 1998.PubMed/NCBI | |
|
Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M and Barak V: Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology. 40:171–176. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Prolla TA: DNA microarray analysis of the aging brain. Chem Senses. 27:299–306. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Choi SH and Suh KY: Interleukin-1 beta,-2,-6 production, serum concentration and hypothalamic-pituitary-adrenal axis in patients with major depression. J Korean Neuropsychiatr Assoc. 37:537–547. 1998. | |
|
Thomas AJ, Davis S, Morris C, Jackson E, Harrison R and O'Brien JT: Increase in interleukin-1β in late-life depression. Am J Psychiatry. 162:175–177. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Corwin EJ, Johnston N and Pugh L: Symptoms of postpartum depression associated with elevated levels of interleukin-1 beta during the first month postpartum. Biol Res Nurs. 10:128–133. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ovaskainen Y, Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E and Vanhala M: Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males. Psychiatry Res. 167:73–79. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Cousins RJ and Leinart AS: Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin 1. FASEB J. 2:2884–2890. 1988.PubMed/NCBI | |
|
Nolan Y, Maher FO, Martin DS, Clarke RM, Brady MT, Bolton AE, Mills KH and Lynch MA: Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J Biol Chem. 280:9354–9362. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
O'Donovan A, Rush G, Hoatam G, Hughes BM, McCrohan A, Kelleher C, O'Farrelly C and Malone KM: Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety. 30:307–314. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Mesquita AR, Correia-Neves M, Roque S, Castro AG, Vieira P, Pedrosa J, Palha JA and Sousa N: IL-10 modulates depressive-like behavior. J Psychiatr Res. 43:89–97. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ledeboer A, Brevé JJ, Wierinckx A, van der Jagt S, Bristow AF, Leysen JE, Tilders FJ and Van Dam AM: Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur J Neurosci. 16:1175–1185. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Ledeboer A, Brevé JJ, Poole S, Tilders FJ and Van Dam AM: Interleukin-10, interleukin-4, and transforming growth factor-β differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia. 30:134–142. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Streit WJ, Sammons NW, Kuhns AJ and Sparks DL: Dystrophic microglia in the aging human brain. Glia. 45:208–212. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kelley KW, O'Connor JC, Lawson MA, Dantzer R, Rodriguez-Zas SL and McCusker RH: Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guérin. Brain Behav Immun. 32:63–69. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Isingrini E, Desmidt T, Belzung C and Camus V: Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease? Curr Opin Investig Drugs. 10:46–55. 2009.PubMed/NCBI | |
|
Rotheneichner P, Lange S, O'Sullivan A, Marschallinger J, Zaunmair P, Geretsegger C, Aigner L and Couillard-Despres S: Hippocampal neurogenesis and antidepressive therapy: shocking relations. Neural Plast. 2014:7239152014.PubMed/NCBI | |
|
Koo JW and Duman RS: IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA. 105:751–756. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Samuels BA, Mendez-David I, Faye C, David SA, Pierz KA, Gardier AM, Hen R and David DJ: Serotonin 1A and serotonin 4 receptors: Essential mediators of the neurogenic and behavioral actions of antidepressants. Neuroscientist. 22:26–45. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ramamoorthy S, Ramamoorthy JD, Prasad PD, Bhat GK, Mahesh VB, Leibach FH and Ganapathy V: Regulation of the human serotonin transporter by interleukin-1 β. Biochem Biophys Res Commun. 216:560–567. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Linthorst AC, Flachskamm C, Müller-Preuss P, Holsboer F and Reul JM: Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: An in vivo microdialysis study. J Neurosci. 15:2920–2934. 1995.PubMed/NCBI | |
|
Linthorst AC, Flachskamm C, Holsboer F and Reul JM: Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. Endocrinology. 135:520–532. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R and Asai M: Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci. 13:3574–3581. 1993.PubMed/NCBI | |
|
Zhu CB, Blakely RD and Hewlett WA: The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology. 31:2121–2131. 2006.PubMed/NCBI | |
|
Sperlágh B, Vizi ES, Wirkner K and Illes P: P2X7 receptors in the nervous system. Prog Neurobiol. 78:327–346. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Clark AK, Staniland AA, Marchand F, Kaan TK, McMahon SB and Malcangio M: P2X7-dependent release of interleukin-1β and nociception in the spinal cord following lipopolysaccharide. J Neurosci. 30:573–582. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Seil M, El Ouaaliti M, Foumekoye S Abdou, Pochet S and Dehaye JP: Distinct regulation by lipopolysaccharides of the expression of interleukin-1β by murine macrophages and salivary glands. Innate Immun. 18:14–24. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Roger S, Mei ZZ, Baldwin JM, Dong L, Bradley H, Baldwin SA, Surprenant A and Jiang LH: Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions. J Psychiatr Res. 44:347–355. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Andó R, Gölöncsér F and Sperlágh B: Modulation of P2X7 receptor function alters depressive behavior in rodent models of depression. Front Neurosci Conference Abstract: IBRO International Workshop 2010. 2010. | |
|
Basso AM, Bratcher NA, Harris RR, Jarvis MF, Decker MW and Rueter LE: Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders. Behav Brain Res. 198:83–90. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lawson MA, McCusker RH and Kelley KW: Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. J Neuroinflammation. 10:542013. View Article : Google Scholar : PubMed/NCBI | |
|
Leutscher PDC, Lagging M, Buhl MR, Pedersen C, Norkrans G, Langeland N, Mørch K, Färkkilä M, Hjerrild S, Hellstrand K, et al: NORDynamIC Group: Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. Hepatology. 52:430–435. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Illman J, Corringham R, Robinson D Jr, Davis HM, Rossi JF, Cella D and Trikha M: Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol. 3:37–50. 2005.PubMed/NCBI | |
|
Xia Z, DePierre JW and Nässberger L: Tricyclic antidepressants inhibit IL-6, IL-1 β and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells. Immunopharmacology. 34:27–37. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB and Miller AH: Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 344:961–966. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Lanquillon S, Krieg JC, Bening-Abu-Shach U and Vedder H: Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 22:370–379. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Trask PC, Esper P, Riba M and Redman B: Psychiatric side effects of interferon therapy: Prevalence, proposed mechanisms, and future directions. J Clin Oncol. 18:2316–2326. 2000.PubMed/NCBI | |
|
Yates WR and Gleason O: Hepatitis C and depression. Depress Anxiety. 7:188–193. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Scheibel RS, Valentine AD, O'Brien S and Meyers CA: Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci. 16:185–191. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Gitlin N: Hepatitis B: Diagnosis, prevention, and treatment. Clin Chem. 43:1500–1506. 1997.PubMed/NCBI | |
|
Horsmans Y: Chronic hepatitis C, depression and interferon. J Hepatol. 42:788–789. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lotrich FE, Rabinovitz M, Gironda P and Pollock BG: Depression following pegylated interferon-alpha: Characteristics and vulnerability. J Psychosom Res. 63:131–135. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Koprich JB, Reske-Nielsen C, Mithal P and Isacson O: Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. J Neuroinflammation. 5:82008. View Article : Google Scholar : PubMed/NCBI | |
|
Sulaiman AH, Zainal NZ, Tan KS and Tan CT: Prevalence and associations of post-stroke depression. Neurol J Southeast Asia. 7:71–75. 2002. | |
|
Broomfield NM, Quinn TJ, Abdul-Rahim AH, Walters MR and Evans JJ: Depression and anxiety symptoms post-stroke/TIA: Prevalence and associations in cross-sectional data from a regional stroke registry. BMC Neurol. 14:1982014. View Article : Google Scholar : PubMed/NCBI | |
|
Ojagbemi A, Owolabi M, Atalabi M and Baiyewu O: Stroke lesions and post-stroke depression among survivors in Ibadan, Nigeria. Afr J Med Med Sci. 42:245–251. 2013.PubMed/NCBI | |
|
Herrmann N, Black SE, Lawrence J, Szekely C and Szalai JP: The Sunnybrook Stroke Study: A prospective study of depressive symptoms and functional outcome. Stroke. 29:618–624. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Herrmann LL, Le Masurier M and Ebmeier KP: White matter hyperintensities in late life depression: A systematic review. J Neurol Neurosurg Psychiatry. 79:619–624. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Upadhyay UM and Tamargo RJ: Inflammation in stroke and focal cerebral ischemia. Surg Neurol. 66:232–245. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Wiart M, Davoust N, Pialat J-B, Desestret V, Moucharrafie S, Cho TH, Mutin M, Langlois JB, Beuf O, Honnorat J, et al: MRI monitoring of neuroinflammation in mouse focal ischemia. Stroke. 38:131–137. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Tynan RJ, Naicker S, Hinwood M, Nalivaiko E, Buller KM, Pow DV, Day TA and Walker FR: Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun. 24:1058–1068. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B and Maj M: The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression. Metab Brain Dis. 24:27–53. 2009. View Article : Google Scholar : PubMed/NCBI |
